Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Mobile, AL
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
University of Southern Alabama Stroke Center
mi
from
Mobile, AL
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Phoenix, AZ
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Catholic Healthcare West
mi
from
Phoenix, AZ
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Scottsdale, AZ
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Tucson, AZ
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
University of Arizona College of Medicine
mi
from
Tucson, AZ
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
San Diego, CA
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
University of California San Diego Medical Center
mi
from
San Diego, CA
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
San Francisco, CA
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Englewood, CO
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Denver
mi
from
Englewood, CO
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Melbourne, FL
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Melbourne
mi
from
Melbourne, FL
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Miami, FL
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Miller School of Medicine University of Miami
mi
from
Miami, FL
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Atlanta, GA
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Emory University
mi
from
Atlanta, GA
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Knoxville, TN
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Mercy Medical Center
mi
from
Knoxville, TN
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Lexington, KY
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
University of Kentucky, Aging/Stroke Program
mi
from
Lexington, KY
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Bethesda, MD
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Suburban Hospital
mi
from
Bethesda, MD
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Boston, MA
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Boston Med Center
mi
from
Boston, MA
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Detroit, MI
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Wayne State
mi
from
Detroit, MI
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Detroit, MI
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Henry Ford Hospital
mi
from
Detroit, MI
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Minneapolis, MN
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Hennepin County Medical Center (Berman Center)
mi
from
Minneapolis, MN
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Rochester, MN
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Mayo Clinic College of Medicine
mi
from
Rochester, MN
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Seattle, WA
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
University of Washington
mi
from
Seattle, WA
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
St. Louis, MO
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
St. Louis Hematology Oncology Specialists, Inc.
mi
from
St. Louis, MO
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Leavenworth, KA
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
St. John's Pediatrics
mi
from
Leavenworth, KA
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Camden, NJ
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Cooper University Hospital
mi
from
Camden, NJ
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Buffalo, NY
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Buffalo
mi
from
Buffalo, NY
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Haverstraw, NY
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Helen Hayes Hospital
mi
from
Haverstraw, NY
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
New York, NY
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Rochester, NY
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Strong Memorial Hospital (University of Rochester School of Medicine)
mi
from
Rochester, NY
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Rochester, NY
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Rochester General Hospital
mi
from
Rochester, NY
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Winston-Salem, NC
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Cleveland, OH
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Metro Health Medical Center
mi
from
Cleveland, OH
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Cleveland, OH
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Case Western Reserve Univ
mi
from
Cleveland, OH
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Columbus, OH
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Ohio State University
mi
from
Columbus, OH
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Portland, OR
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Oregon Health and Science University
mi
from
Portland, OR
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Nashville, TN
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Vanderbilt University Medical Center
mi
from
Nashville, TN
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Dallas, TX
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
UT Soutwestern Medical Center at Dallas
mi
from
Dallas, TX
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Houston, TX
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Scurlock Stroke Center
mi
from
Houston, TX
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
San Antonio, TX
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
The University of Texas Health Science Center at San Antonio, Medical Arts and Research Center
mi
from
San Antonio, TX
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Marshfield, WI
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Marshfield Clinic - Marshfield Center
mi
from
Marshfield, WI
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
mi
from
Milwaukee, WI
Secondary Prevention of Small Subcortical Strokes Trial
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
Status: Archived
Updated: 1/1/1970
Medical College of Wisconsin
mi
from
Milwaukee, WI
Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients
Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients
Status: Archived
mi
from
San Antonio, TX
Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients
Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients
Status: Archived
Updated: 1/1/1970
Center for Neurosurgery Sciences - UTHSCSA - Surgical Intensive Care Unit (SICU)
mi
from
San Antonio, TX
mi
from
Atlanta, GA
Effects of Tetrahydrobiopterin on Blood Pressure
Status: Archived
Updated: 1/1/1970
Emory University
mi
from
Atlanta, GA
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
mi
from
Birmingham, AL
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
University of Alabama at Birmingham
mi
from
Birmingham, AL
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
mi
from
Phoenix, AZ
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Mayo Clinic Phoenix
mi
from
Phoenix, AZ
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
mi
from
Phoenix, AZ
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Arizona Pulmonary Specialist
mi
from
Phoenix, AZ
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
mi
from
Sacramento, CA
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
University of California, Davis Medical Center
mi
from
Sacramento, CA
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
mi
from
Los Angeles, CA
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
West Los Angeles VA Medical Center
mi
from
Los Angeles, CA
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
mi
from
Aurora, CO
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Pulmonary Hypertension Clinic
mi
from
Aurora, CO
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
mi
from
Jacksonville, FL
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
University of Florida - Jacksonville
mi
from
Jacksonville, FL
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
mi
from
Weston, FL
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Cleveland Clinic Florida
mi
from
Weston, FL
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
mi
from
Iowa City, IA
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
University of Iowa
mi
from
Iowa City, IA
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
mi
from
Louisville, KY
FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
A 12-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Comparison of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Kentuckiana Pulmonary Associates
mi
from
Louisville, KY